GGrantIndex
Sort

8,912 grants matching sars cov 2

Molecular mechanisms of aging and accelerated aging in the human brain

$828,774
Maria Mavrikaki · Beth Israel Deaconess Medical Center · R01 · FY2025 · AG

ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.

$828,473
David M Wilson · University Of California, San Francisco · R01 · FY2021 · AI

Defining neutrophil pathobiology in pediatric Long COVID

$828,233
Lael Yonker · Massachusetts General Hospital · R01 · FY2024 · HL

Structure and Dynamics of the SARS-CoV-2 Spike Protein

$828,211
Walther H Mothes · Yale University · R01 · FY2022 · AI

Temporal Phenotypes and Risk Models for the Post-COVID Syndrome and its sub-types

$828,065
Hossein Estiri · Massachusetts General Hospital · R01 · FY2022 · AI

Targeting Angiopoietin-like 4 (ANGPTL4) in Severe Community Acquired Pneumonia

$827,909
Pavan Kumar Bhatraju · University Of Washington · R01 · FY2025 · HL

Neurodifferentiation/Stem Cell Unit

$827,865
David Wang · National Institute Of Neurological Disorders And Stroke · ZIC · FY2024 · NS

Envelope Glycoprotein Incorporation and Function

$827,285
Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Function interactions between mitogen-activated protein kinases (MAPKs) and SARS-CoV-2

$827,164
Jeffrey R Johnson · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI

Leveraging Extensive Social Determinants Data and Spatial Data Science to Reduce HIV Incidence across the United States Ending the HIV Epidemic Counties

$825,988
Yusuf Ransome · Yale University · R01 · FY2024 · MH

Structure and Dynamics of the SARS-CoV-2 Spike Protein

$825,206
Walther H Mothes · Yale University · R01 · FY2023 · AI

High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology

$824,595
Nicholas J Mantis · Wadsworth Center · U01 · FY2023 · CA

Neural, Physiological, Behavioral, and Environmental Risk Markers of Anxiety from Infancy to Adolescence

$824,510
Michelle A Bosquet Enlow · Boston Children'S Hospital · R01 · FY2025 · MH

Neural, Physiological, Behavioral, and Environmental Risk Markers of Anxiety from Infancy to Adolescence

$824,510
Michelle A Bosquet Enlow · Boston Children'S Hospital · R01 · FY2024 · MH

Point-of-care prognostic modeling of PTSD risk after traumatic event exposure using digital biomarkers and clinical data from electronic health records in the emergency department setting (PREDICT)

$824,251
Katharina Schultebraucks · New York University School Of Medicine · R01 · FY2024 · MH

Pulmonary pathophysiology sub-phenotypes of pneumonia

$823,005
Joseph P Mizgerd · Boston University Medical Campus · R01 · FY2023 · AI

Biomarker Investigations for Clinical Trials

$822,832
Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA

Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias

$822,779
John Hsu · Massachusetts General Hospital · U01 · FY2023 · AG

Structure and Dynamics of the SARS-CoV-2 Spike Protein

$822,106
Walther H Mothes · Yale University · R01 · FY2024 · AI

Initiation of immune responses to SARS COV2 in the oral cavity and upper airway

$822,036
Sarah C Glover · University Of Mississippi Med Ctr · R01 · FY2022 · DE

Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches

$821,772
Peng Wu · Scripps Research Institute, The · R01 · FY2025 · AI

Rational design and evaluation of novel mRNA vaccines against MERS-CoV

$821,329
Lanying Du · New York Blood Center · R01 · FY2019 · AI

Evolution of T cell immunity in blood and tissues over childhood

$820,875
Donna L Farber · Columbia University Health Sciences · U01 · FY2022 · AI

North Carolina Seronet Center for Excellence

$820,801
Ralph S Baric · Univ Of North Carolina Chapel Hill · U54 · FY2024 · CA

Point-of-care prognostic modeling of PTSD risk after traumatic event exposure using digital biomarkers and clinical data from electronic health records in the emergency department setting

$820,355
Katharina Schultebraucks · Columbia University Health Sciences · R01 · FY2022 · MH